Stocks and Investing
Stocks and Investing
Thu, December 15, 2016
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, December 14, 2016
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Hartaj Singh Initiated (UTHR) at Buy on, Dec 14th, 2016
Hartaj Singh of Oppenheimer, Initiated "United Therapeutics Corporation" (UTHR) at Buy on, Dec 14th, 2016.
Hartaj has made no other calls on UTHR in the last 4 months.
There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Hartaj's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Hartaj
- Geoff Meacham of "Barclays" Downgraded from Hold to Sell on, Tuesday, November 29th, 2016
- Matthew Kaplan of "Ladenburg Thalmann" Upgraded from Hold to Strong Buy on, Friday, October 28th, 2016
Contributing Sources